Altesa BioSciences (Series B)
Funding Details
Awarder
Inbox
Date Award
February 20, 2026
Vertical
Pharmaceuticals
Funding Amount
$75,000,000
Company Info
Market
Chronic lung diseases
Location
College Park, GA, USA
Coinvestors
Atlantic Partners, Forbion Capital Partners, Medicxi, Pitango Growth, Sanofi
Company Description

Altesa BioSciences is a clinical-stage pharmaceutical company, led by global experts in respiratory medicine and infectious diseases. Altesa is dedicated to improving the lives of people with chronic lung diseases, like COPD and asthma, by treating the principal cause of exacerbations and pathological inflammation - viral respiratory infections.

Links